The market wants numbers. Numbers move the share price. Nothing else. Hype may generate a spike here and there but it won't hold. The earliest numbers we're likely to see won't come from Medizone. They will come from the company marketing the product. Who the sales company is and their projections will give the market something to work with. With the limited info we have, it's just guesswork predicting where the price will go. As additional markets are developed, bigger numbers would be anticipated. I think once things get rolling next year, we'll see a slow and steady increase in the value of the company. Medizone will not mature for many years. However, it;s possible we'll all get a nice Christmas bonus.
Market Data 
Markets 
AI
